Lilly, Boehringer collaborate on diabetes drugs

Links shared publicly online about this topic.

  • 588
    total visits

Lilly, Boehringer collaborate on diabetes drugs

health.yahoo.net

Eli Lilly will pay Boehringer Ingelheim $387.4 million and collaborate with the German drugmaker to develop diabetes drugs with the U.S. pharmaceutical company facing the expiration of some of its key patents.

View full resource at health.yahoo.net

Tags: Diabetes, Diabetes Medication, Drug, Pharma, Eli Lilly and Company, Boehringer Ingelheim

  • Share

Most Recently Shared on January 11, 2011 at 2:40 pm By:

HealthSociety Healthy Society

Lilly, Boehringer collaborate on diabetes drugs http://bit.ly/h8SZ3c

1 year ago...

Boehringer Ingelheim, Lilly receive FDA approval for Jentadueto to treat type 2 diabetes

news-medical.net — “Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) has approved Jentadueto (linagliptin/metformin hydrochloride) tablets, a new tablet combining the dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, and metformin.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on January 31, 2012 at 12:29 pm By:

NewsMedical News-Medical.Net Health News

Boehringer Ingelheim, Lilly receive FDA approval for Jentadueto to treat type 2 diabetes: Boehringer Ingelheim P... http://t.co/QrEPkXXO

3 months ago...

Boehringer-Lilly won't launch Trajenta in Germany | InPharm

inpharm.com — “Boehringer Ingelheim and Lilly have decided not to launch their new diabetes drug Trajenta in GermanyView full resource at inpharm.com

  • View Related
  • Share

Most Recently Shared on September 5, 2011 at 8:37 am By:

Pharmafocus Pharmafocus Pharma and Health News

Boehringer-Lilly won't launch Trajenta in Germany http://ow.ly/6lspG #pharma #diabetes

8 months ago...

Lilly, Boehringer Diabetes Drug Gets European OK - Drugs.com MedNews

drugs.com — “From Associated Press (August 25, 2011) Drug makers Eli Lilly and Co. and Boehringer Ingelheim said Thursday European regulators have approved their type 2 diabView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on August 26, 2011 at 2:09 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Lilly, Boehringer Diabetes Drug Gets European OK: From Associated Press (August 25, 2011) INDIANAPOLIS -- ... http://t.co/bW1yCIu #drug

9 months ago...

Article > Boehringer/Lilly's diabetes drug gets Europe OK

pharmatimes.com — “Article > Boehringer/Lilly's diabetes drug gets Europe OKView full resource at pharmatimes.com

  • View Related
  • Share

Most Recently Shared on August 26, 2011 at 12:05 pm By:

FiercePharma FiercePharma Health Site

Boehringer's diabetes drug Trajenta nabs Euro-approval. To compete w/Merck's Januvia, BMS/AZ's Onglyza. http://t.co/C6DS5ys

9 months ago...

Boehringer-Lilly's Trajenta wins European approval | InPharm

inpharm.com — “Boehringer Ingelheim and Eli Lilly’s new type II diabetes drug Trajenta has been approved EuropeView full resource at inpharm.com

  • View Related
  • Share

Most Recently Shared on August 26, 2011 at 10:05 am By:

Pharmafocus Pharmafocus Pharma and Health News

Boehringer-Lilly's Trajenta wins European approval http://ow.ly/6dnH8 #diabetes #pharma

9 months ago...

Lilly, Boehringer diabetes drug gets European OK - BusinessWeek

businessweek.com — “Drugmakers Eli Lilly and Co. and Boehringer Ingelheim said Thursday European regulators have approved their type 2 diabetes treatment Trajenta.View full resource at businessweek.com

  • View Related
  • Share

Most Recently Shared on August 26, 2011 at 6:54 am By:

Glycosmedia Jim Health News

Lilly, Boehringer diabetes drug gets European OK (Bloomberg) http://t.co/YsFcxV5

9 months ago...

UPDATE 1-Boehringer, Lilly win EU approval for diabetes pill | Reuters

reuters.com — “* Drug branded as Trajenta * U.S. name is Tradjenta * Development pact struck in January (Adds details, background) FRANKFURT, Aug 25 (Reuters) - DrugmakersBoehringer-Ingelheim and Eli LillyView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on August 25, 2011 at 2:22 pm By:

JohnCFierce John Carroll Health Communicator

Boehringer, Lilly get European approval for diabetes drug linagliptin. http://t.co/pp0XtVU

9 months ago...

Lilly diabetes products expand into India - QualityPoint Technologies

qualitypointtech.net — “MUMBAI, July 30 (UPI) -- Eli Lilly India and Lupin Ltd. officials say they entered into a strategic collaboration to promote and distribute Lilly's diabetes medications and products. (Source: Health News - UPI.com)View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on July 30, 2011 at 11:00 pm By:

MedicalFeed MedicalFeed Health News Feed

Lilly diabetes products expand into India: MUMBAI, July 30 (UPI) -- Eli Lilly India and Lupin Ltd. officials say t... http://bit.ly/ooYYld

9 months ago...

Lilly teams up with Disney to help kids with diabetes - Local News - Indianapolis, IN - TODAY.com

today.msnbc.msn.com — “INDIANAPOLIS - Eli Lilly is going to Disney. The drug company announced Thursday morning a major partnership between its Lilly Diabetes division and Disney online. The collaboration will help families who have children with type one diabetes receive education and practical advice in a fun, friendly way.View full resource at today.msnbc.msn.com

  • View Related
  • Share

Most Recently Shared on July 20, 2011 at 5:38 pm By:

FitFactorKids Fit Factor Kids Health Business

Lilly, Disney team up for children with type 1 diabetes. WAY TO GO MICKEY! http://on.today.com/ngNJYi

10 months ago...

EMA CHMP recommends approval of linagliptin for type 2 diabetes

news-medical.net — “Boehringer Ingelheim and Eli Lilly and Company today received a positive opinion from the European Medicines Agency's (EMA) medicinal committee recommending approval of linagliptin, 5 mg, film-coated tablets (to be marketed under the trade name Trajenta® in Europe) for the treatment of adults with type 2 diabetes.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on June 24, 2011 at 8:47 pm By:

Diabetes_Type2 Diabetes, Type 2 OW Health

EMA CHMP recommends approval of linagliptin for type 2 diabetes: Boehringer Ingelheim and Eli Lilly and Company ... http://bit.ly/kjFU5X

11 months ago...

Linagliptin Recommended for Approval in the Treatment of Type 2 Diabetes in Europe | Business Wire

businesswire.com — “Boehringer Ingelheim and Eli Lilly and Company (NYSE:LLY) today received a positive opinion from the European Medicines Agency’s (EMA) medicinalView full resource at businesswire.com

  • View Related
  • Share

Most Recently Shared on June 24, 2011 at 2:45 pm By:

Diabetes_Type2 Diabetes, Type 2 OW Health

Linagliptin Recommended for Approval in the Treatment of Type 2 Diabetes in Europe: INGELHEIM, Germany--(BUSINES... http://bit.ly/jqrcRT

11 months ago...

Boehringer-Lilly launch diabetes drug Tradjenta in US | InPharm

inpharm.com — “Boehringer Ingelheim and Eli Lilly’s new type II diabetes treatment Tradjenta has been launched in the USView full resource at inpharm.com

  • View Related
  • Share

Most Recently Shared on June 16, 2011 at 9:43 am By:

Pharmafocus Pharmafocus Pharma and Health News

Boehringer-Lilly launch diabetes drug Tradjenta in US http://goo.gl/fb/j9lNB

11 months ago...

New Diabetes Drug Tradjenta Approved For Type 2 Diabetes

huffingtonpost.com — “WASHINGTON -- The Food and Drug Administration has approved a new diabetes pill from Boehringer Ingelheim and Eli Lilly for patients who can't control their blood sugar with older medicines. The agency said Monday it approved Tradjenta tablets for adults with type 2 diabetes.View full resource at huffingtonpost.com

  • View Related
  • Share

Most Recently Shared on May 3, 2011 at 7:07 pm By:

Diabetes_Type2 Diabetes, Type 2 OW Health

New Diabetes Drug Approved: WASHINGTON -- The Food and Drug Administration has approved a new diabetes pill fro... http://huff.to/k2R5w9

1 year ago...

New Diabetes Drug Tradjenta Approved For Type 2 Diabetes

huffingtonpost.com — “WASHINGTON -- The Food and Drug Administration has approved a new diabetes pill from Boehringer Ingelheim and Eli Lilly for patients who can't control their blood sugar with older medicines. The agency said Monday it approved Tradjenta tablets for adults with type 2 diabetes.View full resource at huffingtonpost.com

  • View Related
  • Share

Most Recently Shared on May 3, 2011 at 4:44 pm By:

FDA Approves Linagliptin Tablets For The Treatment Of Type 2 Diabetes

medicalnewstoday.com — “Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved linagliptin tablets, a prescription medication used along wView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 3, 2011 at 12:05 pm By:

mnt_drugapprov MNT Drug Approvals Health News

FDA Approves Linagliptin Tablets For The Treatment Of Type 2 Diabetes http://mnt.to/3VjP #regulatory

1 year ago...

Advertisement